Financials
- Market Capitalization 2.12 B
- Employee 975
- Founded 2007
- CEO N/A
- Website www.iovance.com
- Headquarter Delaware, United States
- FIGI BBG000FTLBV7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1917 | BHVN Biohaven Ltd. Common Shares | 14.87 USD | -0.47% | -9.71% | +12.99% | -12.23% | 2.24 B USD | ||
| 1925 | OCUL Ocular Therapeutix, Inc. - Common Stock | 9.96 USD | +2.68% | -1.97% | +8.73% | -13.39% | 2.18 B USD | ||
| 1962 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 23.52 USD | -2.53% | -5.05% | +25.98% | +154.00% | 2.08 B USD | ||
| 1968 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.10 USD | +0.75% | -1.77% | -0.74% | +34.95% | 2.07 B USD |
Frequently asked questions about Iovance Biotherapeutics, Inc. - Common Stock
What is the Iovance Biotherapeutics, Inc. - Common Stock stock price today?
The current price of Iovance Biotherapeutics, Inc. - Common Stock (IOVA) is 4.74. Over the past 24 hours, the stock has changed by +20.61%. Follow the IOVA chart for real-time price dynamics.
What is the stock ticker of Iovance Biotherapeutics, Inc. - Common Stock?
Iovance Biotherapeutics, Inc. - Common Stock trades under the ticker IOVA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Iovance Biotherapeutics, Inc. - Common Stock stock going up?
IOVA has changed by +10.23% over the last week, +22.16% over the last month, and +111.61% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Iovance Biotherapeutics, Inc. - Common Stock net income for the last quarter?
Iovance Biotherapeutics, Inc. - Common Stock reported net income of -79.05 M for the last quarter. The previous quarter showed -71.9 M, which means net income changed by -9.93%.
How many employees does Iovance Biotherapeutics, Inc. - Common Stock have?
As of the latest available data, Iovance Biotherapeutics, Inc. - Common Stock has 975 employees. Workforce size can provide additional context about the company's scale and operations.
What is Iovance Biotherapeutics, Inc. - Common Stock EBITDA?
Iovance Biotherapeutics, Inc. - Common Stock EBITDA is -78.22 M, and its EBITDA margin is -109.51%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Iovance Biotherapeutics, Inc. - Common Stock stock?
You can buy Iovance Biotherapeutics, Inc. - Common Stock (IOVA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Iovance Biotherapeutics, Inc. - Common Stock stock?
Investing in Iovance Biotherapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IOVA chart and related analysis on metatrader.com as part of your research.